1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2020 Financial Results 
August 18, 2020 16:10 ET | Timber Pharmaceuticals
Phase 2b Clinical Trials for Each of the Company’s Lead Assets in Orphan Dermatologic Diseases are Progressing as Planned WOODCLIFF LAKE, NJ, Aug. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Announces European Patent Office Intends to Grant Patent for BPX-01 and BPX-04
July 22, 2020 08:00 ET | Timber Pharmaceuticals
 Stable topical composition has potential to reduce side effects of orally delivered compositions in treatment of acne and rosacea  WOODCLIFF LAKE, NJ, July 22, 2020 (GLOBE NEWSWIRE) -- via...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Announces All CONTROL Study Sites Open and Enrolling Patients with Moderate to Severe Congenital Ichthyosis
July 01, 2020 08:00 ET | Timber Pharmaceuticals
- Phase 2b CONTROL study is evaluating TMB-001 (topical isotretinoin) in subtypes of rare genetic keratinization disorder - - Company also advancing Phase 2b clinical trial evaluating TMB-002...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Announces Appointment of Dr. Gianluca Pirozzi and Edward J. Sitar to Board of Directors
June 04, 2020 08:00 ET | Timber Pharmaceuticals
Decades of experience in drug development and finance to support company advancing novel treatments for rare dermatologic diseases Woodcliff Lake, NJ, June 04, 2020 (GLOBE NEWSWIRE) -- via...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals to Present at the Virtual Summer Summit 
June 03, 2020 08:00 ET | Timber Pharmaceuticals
Presentation on Tuesday, June 9th at 2:10pm ET WOODCLIFF LAKE, NJ, June 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Announces Investor Conference Call
May 19, 2020 16:41 ET | Timber Pharmaceuticals
Call to be held on Tuesday, May 26th at 11:00am EDT WOODCLIFF LAKE, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE...